Blow Fill Seal Technology Market : Notable Developments and Geographical Outlook 2033
The projected trajectory of the global blow fill seal technology market foresees an estimated value of USD 3,246.7 million in 2023, poised to surge to an impressive USD 6,206.5 million by 2033. This upward trend signifies a robust sales revenue expansion, anticipating a notable CAGR of 6.8% throughout the forecast period.
The burgeoning pharmaceutical industry, coupled with
manufacturers increasingly embracing advanced sterilization technologies like
blow fill seal (BFS), is set to propel the global market forward. The adoption
of BFS addresses concerns related to human intervention and mitigates the risks
of drug contamination during the filling and packaging processes.
This technology presents a myriad of advantages, including
packaging flexibility, reduced operating costs, high-level sterility assurance,
minimal space and component inventory requirements, as well as a limited
workforce necessity. These attributes collectively position BFS as an ideal
technology for pharmaceutical companies engaged in drug packaging applications.
Get the Complete Story—Read
More About Our Latest Report!
The latest generation of aseptic blow-fill-seal technology
machines is specifically dedicated to a whole new range of adapted insertion
applications. These modular insertion isolators are typically located outside
the categorized machine room, separate from but directly connected to the B/F/S
unit through a transfer tunnel.
The isolator and tunnel are typically sterilized with
vaporized hydrogen peroxide, and the Class 100 environment within it is
maintained by HEPA filtration. This new addition to the aseptic B/F/S system
has not only streamlined the insertion process but has also provided a higher
level of sterility assurance for products with tips-and-caps and
rubber/silicone stoppers inserted under aseptic conditions.
This technology was introduced by Rommelag, incorporating
insertion with blow-fill-seal, resulting in an advanced blow-fill-insert-seal
technology. During the insertion process, either a preservative-free multi-dose
system or a micro-brittle applicator could be inserted according to the
requirements.
“Unit dosage packaging, such as prefilled syringes, is
in high demand. This, in turn, is spurring the demand for blow-fill-seal
technology in the global market. In response to this market dynamic,
pharmaceutical companies are strategically integrating BFS technology into
their manufacturing processes to meet the escalating demand for unit dose
packaging.”- Says Future Market Insights.
Key Takeaways from the Global Blow Fill Seal Technology
Market
- Prefilled
syringes and injectable lead the global BFS technology market, capturing
half of the value share and are anticipated to increase by 340 BPS points
during the forecast period. Ampoules are growing at a CAGR of 6.4% and are
expected to gain 1/5th of the market share by the end of 2033. Bottles
will gain incremental opportunities worth USD 507.8 million by the end of
the forecast years.
- Polyethylene
is dominating the market, gaining more than 61% of the market share in
2023, creating an incremental growth opportunity of USD 2,013.4 million by
the end of 2033. Polypropylene is anticipated to record 6.5% during
2023-2033, with an expansion rate of 1.9 times its current market value.
- The
pharmaceutical industry is the prominent user of BFS technology, with 97%
of the market share driven by rapid expansion. In the pharmaceutical
industry, respiratory is anticipated to generate 1,202.4 million
incremental growth opportunities during the forecast years. Food and
beverage are expected to expand 1.8 times its current market value in the
upcoming years.
Global Blow Fill Seal Technology Market Landscape
Unither Pharmaceuticals SAS, Rommelag SE & Co. KG,
Woodstock Sterile Solutions, Curida AS, New Vision Pharmaceuticals LLC, Weiler
Engineering Inc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited,
Nephron Pharmaceuticals Corporation, Horizon Pharmaceuticals Inc, are some of
the noticeable players in the market. The tier 1 players in the market hold
10–15% of the overall blow fill seal technology market including
GlaxoSmithKline plc, Takeda Pharmaceuticals International AG, and Horizon
Pharmaceuticals Plc.
Key Developments
- In
December 2021, Woodstock secured a United States patent for their cold
blow fill seal system. This innovative approach involves meticulous
temperature control to prevent heat-related damage. It is particularly
suitable for medications susceptible to temperature-induced degradation.
- In
January 2021, Berry Global Healthcare introduced Cyrano, their latest
blow-fill-seal closure, renowned for its lightweight design. Tailored to
minimize plastic usage, Cyrano serves as an accessible solution for
various intravenous and infusion systems.
Global Blow fill Seal Technology Market by Category
By Product:
- Bottles
- 0.2–100ml
- 100–500ml
- Above
500 ml
- Ampoules
- 0.1–10ml
- 10–100ml
- Vials
- 0.1–10ml
- 10–50ml
- Others
(Prefilled Syringes Cartridges & Injectable)
By Material:
- PE
- LDPE
- HDPE
- PP
- Others
(EVOH etc.)
By End Use:
- Pharmaceuticals
- Ophthalmic
- Injectable
- Biologics
- Wound
care
- Respiratory
Therapy
- Food
& Beverage(incl. Nutraceuticals)
- Cosmetics
and Personal Care
- Others
(Chemicals etc.)
By Region:
- North
America
- Latin
America
- Asia
Pacific Excluding Japan
- Western
Europe
- Eastern
Europe
- Middle
East and Africa
- Japan
Comments
Post a Comment